The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Insmed has claimed the distinction of becoming the first company to get FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis (NCFB). The US regulator cleared DPP1 ...

This tool is a command-line client for the SSL Labs APIs, designed for automated and/or bulk testing. If you'd like to contribute, please have a look at the TODO file. For larger work, please get in ...

New Scan Method Unveils Lung Function Secrets Dec. 25, 2024 A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with ...